| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |